Invite a friend to get their first reward.Claim 1000 Satoshis

I'm searching

For Hoomans

You're not logged in. Please log in to earn stock or Bitcoin rewards on your prescription purchase.

Pegasys

Pegasys, the brand name for peginterferon alfa-2a, is an antiviral medication used to treat chronic hepatitis B and chronic hepatitis C infections in adults. Pegasys belongs to a class of drugs known as interferons, which help boost the body's immune system to fight off viral infections. Pegasys is often used in combination with other antiviral medications to improve its effectiveness in treating hepatitis C. It helps reduce the amount of virus in the body, slowing liver damage, and improving liver function.

Oops! We currently don’t have the pricing information for this drug.

But we're continually improving our service to help you save and earn rebates on your medications. If your drug isn't listed on NiHowdy, you can still present your NiHowdy savings card at the pharmacy. We'll work to secure any eligible rebates for that drug and pass the savings back to you retroactively.

backgroundbackground

Members have saved

$NaN

using our savings card for instant savings.
Don't pay full retail price and miss out on potential savings. Try it now—you have nothing to lose!

NaNM

worth of Satoshi has been rewarded to our members.
Everyone who signs up enjoys the benefits of earning FREE Bitcoin with every purchase.

Frequently Asked Questions

How long does it take for Pegasys to work?
Open FAQClose FAQ

The effects of Pegasys vary based on the condition being treated. For hepatitis C, viral load reduction may be seen within the first few weeks of treatment, but the full course usually lasts 48 weeks. For hepatitis B, it may take several months to see improvement in liver function.

Can Pegasys cure hepatitis C?
Open FAQClose FAQ

Pegasys, when used in combination with other antiviral medications, can lead to a sustained virologic response (SVR), which means the virus is no longer detectable after treatment. This is considered a functional cure for hepatitis C, though it is not guaranteed for all patients.

What should I do if I miss a dose of Pegasys?
Open FAQClose FAQ

If you miss a dose, take it as soon as you remember unless it is close to the time of your next dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not double up on doses.

Can Pegasys be used during pregnancy?
Open FAQClose FAQ

Pegasys is generally not recommended during pregnancy, especially when used in combination with ribavirin, which can cause birth defects. Women of childbearing age should use effective contraception during treatment.

What should I do if I experience flu-like symptoms after taking Pegasys?
Open FAQClose FAQ

Flu-like symptoms are common with Pegasys, especially in the first few weeks of treatment. To manage these symptoms, stay hydrated, rest, and consider taking over-the-counter medications like acetaminophen (Tylenol) to reduce fever or pain. If the symptoms are severe or persistent, contact your healthcare provider.

Comprehensive Drug Guide

How Does Pegasys Work?

Pegasys contains peginterferon alfa-2a, a long-acting form of interferon that helps the body’s immune system fight off viral infections by enhancing the activity of immune cells, including natural killer cells and macrophages. It also inhibits viral replication by interfering with the ability of viruses to multiply in infected cells. This immune-enhancing effect helps reduce the amount of hepatitis B or C virus in the body, improving liver function and slowing the progression of liver disease.

Common Dosages

  • 180 mcg/0.5 mL prefilled syringes or autoinjectors.

Typical Dosing

  • For chronic hepatitis C: The typical dose is 180 mcg once weekly for 48 weeks, though the duration may vary depending on the specific genotype of the virus and whether Pegasys is used in combination with other antiviral drugs.
  • For chronic hepatitis B: The usual dose is 180 mcg once weekly for 48 weeks, though the duration may vary based on response to treatment.

Pegasys is administered subcutaneously (under the skin), usually in the abdomen or thigh.

Typical Dosing

FDA Approved Indications

  • Chronic hepatitis C in adults, often in combination with other antiviral medications (such as ribavirin or sofosbuvir).
  • Chronic hepatitis B in adults with evidence of active viral replication and liver inflammation.

Who Shouldn't Take Pegasys?

  • Autoimmune hepatitis.
  • Decompensated liver disease (such as cirrhosis with significant liver damage).
  • Severe psychiatric conditions, including uncontrolled depression or suicidal thoughts.
  • Severe heart disease, including recent heart attack or severe arrhythmias.
  • Known hypersensitivity to interferons or any component of the formulation.

Advice From The Pharmacist

  • Administer Pegasys exactly as prescribed. Follow your healthcare provider's instructions for injecting the medication subcutaneously. If self-administering, ensure you receive proper training on injection techniques.
  • Store Pegasys in the refrigerator, but do not freeze it. Allow the medication to reach room temperature before injecting it.
  • Rotate injection sites to prevent irritation and tissue damage. Use a new needle for each injection.
  • Stay hydrated while using Pegasys to help minimize side effects such as fever and fatigue.
  • Report any mood changes or symptoms of depression to your healthcare provider immediately, as Pegasys can cause psychiatric side effects, including depression and suicidal thoughts.

Side Effects of Pegasys

Common Side Effects

  • Flu-like symptoms (fever, chills, muscle aches, headache)
  • Fatigue
  • Nausea
  • Loss of appetite
  • Irritability
  • Injection site reactions (redness, swelling, or pain)

Uncommon/Severe Side Effects

  • Depression or suicidal thoughts: Pegasys can cause or worsen depression. Patients should be monitored closely for changes in mood or behavior.
  • Blood disorders: Pegasys can cause low white blood cell counts (neutropenia), low platelet counts (thrombocytopenia), and anemia.
  • Liver problems: In patients with hepatitis, Pegasys can sometimes worsen liver function, leading to jaundice, severe abdominal pain, or dark urine.
  • Autoimmune disorders: Rarely, Pegasys can trigger or worsen autoimmune conditions such as thyroid disease, lupus, or rheumatoid arthritis.

Risks and Warnings of Pegasys

  • Psychiatric effects: Pegasys can cause or worsen psychiatric conditions, including depression, anxiety, or suicidal thoughts. Patients with a history of psychiatric illness should be monitored closely during treatment.
  • Blood cell abnormalities: Pegasys can cause low levels of white blood cells, red blood cells, and platelets, increasing the risk of infections, anemia, and bleeding. Regular blood tests are required to monitor for these effects.
  • Autoimmune diseases: Pegasys may exacerbate or trigger autoimmune conditions. Patients with a history of autoimmune disease should use Pegasys cautiously.
  • Heart disease: Patients with heart disease, particularly those with a history of heart failure or arrhythmias, may experience worsening of their condition while on Pegasys.

Interactions with Pegasys

Common Drug Interactions

  • Immunosuppressants: Using Pegasys with other immunosuppressive drugs (e.g., corticosteroids or biologics) may reduce the immune response or increase the risk of infections.
  • Antiviral medications: Pegasys is often used in combination with other antiviral drugs like ribavirin or sofosbuvir to enhance its effectiveness against hepatitis C.
  • Psychiatric medications: Pegasys can interact with antidepressants or antipsychotics, increasing the risk of psychiatric side effects.

Alternatives to Pegasys

  • Epclusa (sofosbuvir/velpatasvir): An oral antiviral medication used to treat all genotypes of chronic hepatitis C without the need for interferon.
  • Harvoni (ledipasvir/sofosbuvir): An oral antiviral used to treat hepatitis C, particularly in genotype 1.
  • Baraclude (entecavir): An oral antiviral used to treat chronic hepatitis B.
  • Vemlidy (tenofovir alafenamide): Another antiviral option for treating chronic hepatitis B.